DoD Accelerating Innovation in Military Medicine Research Award | W81XWH 18 DMRDP AIMM

Opportunity Information: Apply for W81XWH 18 DMRDP AIMM

The Department of Defense Accelerating Innovation in Military Medicine (AIMM) Research Award is a discretionary research and development funding opportunity run through the U.S. Army Medical Research Acquisition Activity (USAMRAA) under CFDA 12.420. It is designed to back bold, high-risk, high-reward ideas in military health and medicine, especially projects that are genuinely inventive and could drive major leaps forward rather than incremental progress. The core emphasis is on research that could accelerate critical discoveries or lead to major advancements with clear potential to improve outcomes for service members and military-relevant patient populations.

AIMM specifically targets conceptually innovative work that might struggle to fit into more traditional funding lanes or established core programs. In practice, that means the program is looking for potential "game-changers" that initiate new directions, open up entirely new technical approaches, or rapidly elevate an emerging concept into something that can meaningfully impact military medicine. The solicitation signals strong interest in proposals that use synthetic biology or systems biology approaches, as well as projects centered on autonomous healthcare, reflecting a push toward next-generation tools, platforms, and decision-making systems that can operate effectively in austere, distributed, or operational environments.

The funding instrument types listed are grants and cooperative agreements, which indicates awards may range from more traditional investigator-led grants to more actively managed cooperative arrangements where the government can have substantial involvement in project direction or coordination. The opportunity was open in 2018 with an original closing date of January 2, 2019, and it anticipated making around six awards. The published award ceiling is shown as 0, which usually means a specific maximum was not provided in the posted summary and would typically be defined in the full solicitation, tied to available funds, or dependent on the scope and justification of the proposed work.

Eligibility is described as unrestricted, meaning a wide range of applicant organizations could apply (for example, universities, nonprofits, companies, research institutes, and other entities), subject to any additional eligibility clarifications in the full announcement. Overall, AIMM is positioned as a catalyst program within DoD medical R&D: it seeks ambitious, creatively designed projects with a plausible pathway to outsized impact on military health and medicine, particularly where emerging biological engineering methods or autonomous care concepts could change what is possible in future military medical capabilities.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Accelerating Innovation in Military Medicine Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Aug 07, 2018.
• Applicants must submit their applications by Jan 02, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 6 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 18 DMRDP AIMM

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: